News Incyte Reports Topline Data from P-III (STOP-HS1 & STOP-HS2) Trials of Povorcitinib (INCB054707) for Hidradenitis Suppurativa (HS)ByRidhi RastogiMarch 18, 20250Comments
THOUGHTSPOT Bridging the Gap Between Conventional and Integrative MedicineBySelina GranMarch 18, 20250Comments
News NANOBIOTIX and Janssen Amend Partnership to Develop and Commercialize JNJ-1900 (NBTXR3)ByRidhi RastogiMarch 18, 20250Comments
INSIGHTS+ EMA Marketing Authorization of New Drugs in February 2025ByDipanshu DixitMarch 18, 20250Comments
News Alvotech and Dr. Reddy’s Report the US FDA’s BLA Acceptance for AVT03 (Biosimilar, Prolia and Xgeva) ByDipanshu DixitMarch 18, 20250Comments
News AstraZeneca Reports the EC’s Approval of Imfinzi to Treat Limited-Stage Small Cell Lung Cancer (LS-SCLC)ByRidhi RastogiMarch 17, 20250Comments
News Perfuze Secures the US FDA’s 510(k) Clearance for its Zipline Access CathetersByRidhi RastogiMarch 17, 20250Comments
News AstraZeneca and Alteogen Enter an Exclusive License Deal for ALT-B4 to Develop & Market Subcutaneous Formulations of Multiple Oncology DrugsByRidhi RastogiMarch 17, 20250Comments
